I just had the opportunity to attend this year’s American Society of Gene & Cell Therapy (ASGCT) annual meeting — one of my favorite conferences o…

Every year in November, Vertex joins the alpha-1 antitrypsin deficiency community in recognizing AATD Awareness Month. To help raise awareness about t…

At Vertex, we believe the most important medicines are those that have transformative impact for patients. And while drug discovery and development ar…

I remember first learning about CRISPR years ago and thinking, “this technology could really work.” At the time, I didn’t realize that I would get to …

This year, Vertex turns 30. For three decades, some of the best and brightest minds in science and medicine – known around here as ‘Vertexians’ – …

As CEO of Vertex since 2012, I’ve had the privilege of building personal connections with many different people in the cystic fibrosis (CF) community …